These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30557493)

  • 1. [iPSCs and aging].
    Sakuma I; Tanaka T
    Nihon Rinsho; 2016 Sep; 74(9):1560-1564. PubMed ID: 30557493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPSCs-based anti-aging therapies: Recent discoveries and future challenges.
    Pareja-Galeano H; Sanchis-Gomar F; Pérez LM; Emanuele E; Lucia A; Gálvez BG; Gallardo ME
    Ageing Res Rev; 2016 May; 27():37-41. PubMed ID: 26921478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Aging Strategies Based on Cellular Reprogramming.
    Ocampo A; Reddy P; Belmonte JCI
    Trends Mol Med; 2016 Aug; 22(8):725-738. PubMed ID: 27426043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cellular rejuvenation.
    Denoth-Lippuner A; Jessberger S
    FEBS Lett; 2019 Dec; 593(23):3381-3392. PubMed ID: 31197818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elixir of Life: Thwarting Aging With Regenerative Reprogramming.
    Beyret E; Martinez Redondo P; Platero Luengo A; Izpisua Belmonte JC
    Circ Res; 2018 Jan; 122(1):128-141. PubMed ID: 29301845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues.
    Alle Q; Le Borgne E; Milhavet O; Lemaitre JM
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells.
    Phanthong P; Raveh-Amit H; Li T; Kitiyanant Y; Dinnyes A
    Biogerontology; 2013 Dec; 14(6):591-602. PubMed ID: 23963527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejuvenation of Cardiac Tissue Developed from Reprogrammed Aged Somatic Cells.
    Cheng Z; Peng HL; Zhang R; Fu XM; Zhang GS
    Rejuvenation Res; 2017 Oct; 20(5):389-400. PubMed ID: 28478705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging and reprogramming: a two-way street.
    Mahmoudi S; Brunet A
    Curr Opin Cell Biol; 2012 Dec; 24(6):744-56. PubMed ID: 23146768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming and transdifferentiation shift the landscape of regenerative medicine.
    Guo J; Wang H; Hu X
    DNA Cell Biol; 2013 Oct; 32(10):565-72. PubMed ID: 23930590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular reprogramming: A new way to understand aging mechanisms.
    Yener Ilce B; Cagin U; Yilmazer A
    Wiley Interdiscip Rev Dev Biol; 2018 Mar; 7(2):. PubMed ID: 29350802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPSCs as a major opportunity to understand and cure age-related diseases.
    Lemey C; Milhavet O; Lemaitre JM
    Biogerontology; 2015 Aug; 16(4):399-410. PubMed ID: 25981448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Production and Application of Induced Pluripotent Stem Cells.
    Mortada I; Bilani N
    Curr Stem Cell Res Ther; 2017; 12(8):637-643. PubMed ID: 28969537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking to the future following 10 years of induced pluripotent stem cell technologies.
    Li M; Izpisua Belmonte JC
    Nat Protoc; 2016 Sep; 11(9):1579-85. PubMed ID: 27490631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
    Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
    J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo reprogramming for tissue regeneration and organismal rejuvenation.
    Taguchi J; Yamada Y
    Curr Opin Genet Dev; 2017 Oct; 46():132-140. PubMed ID: 28779646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.